Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Genentech; Genentech Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Active, not recruiting - verified September 2013

This is a Phase 3, open-label, uncontrolled, extension study to assess the long-term efficacy and safety of lesinurad monotherapy in subjects who completed the double-blind treatment period in Study R...

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Completed - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Active, not recruiting - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: BIIB057; Drug: Placebo Sponsors : Biogen Idec; Biogen Idec; Biogen Idec Research Ltd.; Biogen Idec MA Inc. Withdrawn - verified October 2012